Related Experiment Video
Updated: Mar 24, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Probable Levofloxacin-associated Secondary Intracranial Hypertension in a Child With Multidrug-resistant Tuberculosis
Louvina E van der Laan1, H Simon Schaaf, Regan Solomons
1From the *Desmond Tutu TB Centre, Department of Pediatrics and Child Health, ‡Department of Pediatrics and Child Health, and §Department of Ophthalmology, Faculty of Medicine and Health Sciences, Stellenbosch University; and †Brooklyn Hospital for Chest Diseases, Cape Town, South Africa.
Insights
Levofloxacin may cause intracranial hypertension in children with multidrug-resistant tuberculosis. Early ophthalmologic screening is crucial for pediatric patients on prolonged fluoroquinolone treatment.
Area of Science:
- Pediatric Infectious Diseases
- Pharmacovigilance
- Neurology
Background:
- Multidrug-resistant tuberculosis (MDR-TB) treatment often involves fluoroquinolones.
- Fluoroquinolones are essential for managing complex TB cases.
- Prolonged use of these antibiotics is common in MDR-TB patients.
Observation:
- A 6-year-old girl with pulmonary MDR-TB developed intracranial hypertension.
- This adverse event was possibly linked to levofloxacin therapy.
- The patient presented with signs and symptoms suggestive of increased intracranial pressure.
Findings:
- This case represents the first report of probable levofloxacin-associated intracranial hypertension in a child.
- The findings suggest a potential risk of secondary intracranial hypertension in pediatric MDR-TB patients undergoing extended fluoroquinolone treatment.
- Ophthalmologic evaluation is recommended for children exhibiting relevant symptoms.
Implications:
- Highlights the importance of monitoring for intracranial hypertension in children receiving fluoroquinolones for MDR-TB.
- Underscores the need for proactive ophthalmologic screening in this vulnerable pediatric population.
- Informs clinical practice regarding the safe use of levofloxacin in pediatric MDR-TB management.
Abstract:
Fluoroquinolones are a key component of multidrug-resistant tuberculosis treatment. We describe the first reported case of probable levofloxacin-associated intracranial hypertension in a 6-year-old girl with pulmonary multidrug-resistant tuberculosis. The case highlights the potential risk of secondary intracranial hypertension in multidrug-resistant tuberculosis patients who require prolonged fluoroquinolone therapy and the need for ophthalmologic screening in children with suggestive signs and symptoms.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:58Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry LCM-LC/MS
Published on: April 18, 2018
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Inhibitors of Bacterial DNA Synthesis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Acute Pyelonephritis II: Diagnostic Studies and Management